Based on the Renascience Inc. stock forecast from 0 analysts, the average analyst target price for Renascience Inc. is not available over the next 12 months. Renascience Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Renascience Inc. is Very Bearish, which is based on 0 positive signals and 9 negative signals. At the last closing, Renascience Inc.’s stock price was JPY 272.00. Renascience Inc.’s stock price has changed by -2.86% over the past week, -9.93% over the past month and -33.00% over the last year.
No recent analyst target price found for Renascience Inc.
No recent average analyst rating found for Renascience Inc.
Company Overview Renascience Inc.
Renascience Inc. engages in the development and commercialization of pharmaceuticals and medical devices in Japan. The company is developing RS5614, a PAI-1 inhibitor product candidate for use in the treatment of chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets that is in Phase 3 clinical trials; RS5441, a PAI-1 inhibitor for use in dermatological diseases that is in Phase I clinical trials; and RS8001, a water-soluble vitamin for use in the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder, which is in Phase 2 clinical trials. It is also developing RS9001, a disposable ultrafine endoscope; artificial intelligence based medical solutions; and diagnostic solutions. The company was incorporated in 2000 and is headquartered in Tokyo, Japan. Read Less
Renascience Inc. engages in the development and commercialization of pharmaceuticals and medical devices in Japan. The company is developing RS5614, a PAI-1 inhibitor product candidate for use in the treatment of chronic myeloid leukemia, malignant melanoma, non-small cell lung c...Read More
Frequently Asked Questions About Renascience Inc. (4889:TSE) Stock
Stock Target Advisor's fundamental analysis for Renascience Inc.'s stock is Very Bearish.
Unfortunately we do not have enough data on 4889:TSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4889:TSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4889:TSE's stock to indicate if its overvalued.
The last closing price of 4889:TSE's stock was JPY 272.00.
The most recent market capitalization for 4889:TSE is JPY 3.61B.
Unfortunately we do not have enough analyst data on 4889:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Renascience Inc.'s stock.
As per our most recent records Renascience Inc. has 4 Employees.
Renascience Inc.'s registered address is 401 Kyodo Building, Tokyo, Japan, 103-0023.
You can get more information about it from Renascience Inc.'s website at https://www.renascience.co.jp.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Renascience Inc. (4889:TSE) Stock
Stock Target Advisor's fundamental analysis for Renascience Inc.'s stock is Very Bearish.
Unfortunately we do not have enough data on 4889:TSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4889:TSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4889:TSE's stock to indicate if its overvalued.
The last closing price of 4889:TSE's stock was JPY 272.00.
The most recent market capitalization for 4889:TSE is JPY 3.61B.
Unfortunately we do not have enough analyst data on 4889:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Renascience Inc.'s stock.
As per our most recent records Renascience Inc. has 4 Employees.
Renascience Inc.'s registered address is 401 Kyodo Building, Tokyo, Japan, 103-0023.
You can get more information about it from Renascience Inc.'s website at https://www.renascience.co.jp.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4889:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
